Proof from the field.
How Medtech Incubator has taken medtech companies from a first meeting to a national contract, a protected GPO award and a Johnson & Johnson acquisition.
-
Spine · U.S. market entry
Thinking Outside the Cage
How a German spine start-up went from its first U.S. case to a Johnson & Johnson acquisition in under a year, with OSP Advisors leading its U.S. commercialization.
- 12,000
- European cases before U.S. entry
- ~75
- U.S. implants in the first six weeks
- < 1 year
- first U.S. case to acquisition
-
Biologics · GPO contract
From Off-Contract Risk to a Protected GPO Contract
How OSP Advisors helped a physician-owned, early-stage biologics company win a GPO award and grow 40% in its first year on contract.
- 40%
- GPO business growth, year one
- 10 months
- to contract award
- $8M
- off-contract spend protected
-
Bone biologics · HCA Healthcare
From Commodity Product to an HCA National Contract
How a confidential bone biologics company won an HCA Healthcare national purchasing contract with little to no spend, then carried the win into HCA’s ambulatory surgery centers.
- ~12 months
- first meeting to national contract
- Minimal
- sales force and marketing spend
- 2 settings
- acute care hospitals, then ASCs
Facing a contract review or a U.S. launch?
Let’s map the fastest path to your contract, your launch or your exit.